BioMimetic Therapeutics, Inc. Announces Completion of Rights Offering and Sale of Shares in Standby Purchase BioMimetic Therapeutics, Inc. announced that it has closed its previously announced rights offering. The Company received valid subscriptions for all of shares purchasable in the rights offering, including shares subscribed for by certain of the Company's stockholders in the exercise of their over-subscription rights, at a subscription price of $8.50 per share. The Company issued the shares purchased in the rights offering to the purchasers on June 2009. [more...]
